Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCode ▲DrugDate fromSubject
 13.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))12.2.2024O
 2.7.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))1.7.2024R
 10.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99946Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 10x500 mg (blis.PP/Al))10.10.2024O
 19.9.2022GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)9989CPANADOL PRE DETI JAHODA 24 mg/ml (sus por 1x100 ml (fľ.skl. hnedá+8 ml aplikátor-povolenie uvádzať na trh končí dňa 28.02.2023))16.9.2022Z
 14.12.2023Orion Corporation (ORN)99860BECLOMET NASAL AQUA 100 µg (aer nas 1x23 ml/200 dávok (fľ.HDPE))14.12.2023R
 18.1.2024Orion Corporation (ORN)99860BECLOMET NASAL AQUA 100 µg (aer nas 1x23 ml/200 dávok (fľ.HDPE))18.1.2024O
 24.11.2022Viatris Limited (VIM)9981DTutecvi Combi 50 mg/850 mg (tbl flm 60x50 mg/850 mg (blis.Al/OPA/Al/PVC))24.11.2022U
 24.11.2022Viatris Limited (VIM)9974DTutecvi Combi 50 mg/1000 mg (tbl flm 60x50 mg/1000 mg (blis.Al/OPA/Al/PVC))24.11.2022U
 19.10.2023Janssen - Cilag International N.V. (JNS)9965AVokanamet 150 mg/1000 mg filmom obalené tablety (tbl flm 60x150 mg/1000 mg (fľ.HDPE))19.10.2023R
 6.6.2024Janssen - Cilag International N.V. (JNS)9965AVokanamet 150 mg/1000 mg filmom obalené tablety (tbl flm 60x150 mg/1000 mg (fľ.HDPE))6.6.2024O
 25.5.2022Zentiva, k.s. (ZNT-1)99600ZODAC (tbl flm 90x10 mg (blis.PVC/PVDC/Al))25.5.2022R
 17.6.2022Zentiva, k.s. (ZNT-1)99600ZODAC (tbl flm 90x10 mg (blis.PVC/PVDC/Al))21.6.2022O
 27.4.2023Zentiva, k.s. (ZNT-1)99600ZODAC (tbl flm 90x10 mg (blis.PVC/PVDC/Al))28.4.2023R
 16.5.2023Zentiva, k.s. (ZNT-1)99600ZODAC (tbl flm 90x10 mg (blis.PVC/PVDC/Al))22.5.2023O
 12.4.2024Janssen - Cilag International N.V. (JNS)9959AVokanamet 50 mg/1000 mg filmom obalené tablety (tbl flm 60x50 mg/1000 mg (fľ.HDPE))12.4.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To